
Israel's parliament on Monday approved a controversial bill to reintroduce the death penalty for terrorists, a move considered racist by critics as the legislation would effectively only apply to Palestinians.
Rights organizations and several European countries had called for the initiative to be stopped.
Under the bill, Palestinians convicted of murder as an act of terrorism by military courts in the occupied territories would face a mandatory death sentence.
In civilian courts in Israel, meanwhile, a person convicted of murder with a terrorism motive with the aim of destroying the State of Israel could be sentenced either to death or to life imprisonment under the law.
The bill was introduced by the Otzma Yehudit party of far-right Minister of National Security Itamar Ben-Gvir.
A total of 62 of 120 lawmakers in the Knesset backed the bill in a final vote on Monday, including Prime Minister Benjamin Netanyahu. A total of 48 lawmakers voted against the bill, while the rest abstained or were not present for the vote.
LATEST POSTS
- 1
Horses really can smell our fear, new study finds - 2
Fetterman says he's back home after a fall put the Pennsylvania senator in the hospital - 3
Jubilant FoodWorks to scrap Dunkin’ franchise arrangement in India - 4
Manual for Instructive Application for Youngsters - 5
Iranian naval commander Alireza Tangsiri killed in attack, says Israel
Why won't NASA's Artemis 2 astronauts land on the moon when they get there?
The Golden Globes gift bag has nearly $1 million worth of swag for some winners and presenters. What's in it?
'Every day I planned an escape': Ariel Cunio shares details of Hamas captivity
Astronomers may have spotted the 1st known 'superkilonova' double star explosion
British Columbia's Secret Lakeside Town With Hot Springs Is 'An Oasis Of Arts, Culture And Relaxation'
25 of the world’s best sandwiches
Top notch DSLR Cameras for Photography Devotees
Winter solstice 2025 marks the shortest day of the year in the Northern Hemisphere today
BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet













